Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The company is headquartered in Hingham, Massachusetts and currently employs 21 full-time employees. The company has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. The company specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. The company eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue
0
0
0
0
0
0
Revenue Growth (YoY)
--
--
--
--
--
--
Cost of Revenue
--
--
--
--
--
--
Gross Profit
--
--
--
--
--
--
Selling, General & Admin
8
8
5
4
5
5
Research & Development
6
6
6
5
7
5
Operating Expenses
14
14
11
9
13
11
Other Non Operating Income (Expenses)
--
--
--
--
--
--
Pretax Income
-13
-13
-11
-10
-13
-11
Income Tax Expense
--
--
--
--
--
--
Net Income
-13
-13
-11
-10
-13
-11
Net Income Growth
18%
18%
10%
-23%
18%
22%
Shares Outstanding (Diluted)
67.3
45.79
15.64
10.2
7.26
7.11
Shares Change (YoY)
292%
193%
53%
41%
2%
0%
EPS (Diluted)
-0.19
-0.28
-0.73
-1.05
-1.81
-1.59
EPS Growth
-71%
-61%
-31%
-42%
14%
23%
Free Cash Flow
-13
-13
-8
-8
-11
-9
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
--
--
--
--
--
--
Operating Margin
0%
0%
0%
0%
0%
0%
Profit Margin
0%
0%
0%
0%
0%
0%
Free Cash Flow Margin
0%
0%
0%
0%
0%
0%
EBITDA
-14
-14
-11
-9
-13
-11
EBITDA Margin
0%
0%
0%
0%
0%
0%
D&A For EBITDA
0
0
0
0
0
0
EBIT
-14
-14
-11
-9
-13
-11
EBIT Margin
0%
0%
0%
0%
0%
0%
Effective Tax Rate
--
--
--
--
--
--
Follow-Up Questions
What are Microbot Medical Inc's key financial statements?
According to the latest financial statement (Form-10K), Microbot Medical Inc has a total asset of $81, Net loss of $-13
What are the key financial ratios for MBOT?
Microbot Medical Inc's Current ratio is 27, has a Net margin is 0, sales per share of $0.
How is Microbot Medical Inc's revenue broken down by segment or geography?
Microbot Medical Inc largest revenue segment is Commissions, at a revenue of 5,937,532 in the most earnings release.For geography, United States is the primary market for Microbot Medical Inc, at a revenue of 10,856,612.
Is Microbot Medical Inc profitable?
no, according to the latest financial statements, Microbot Medical Inc has a net loss of $-13
Does Microbot Medical Inc have any liabilities?
yes, Microbot Medical Inc has liability of 3
How many outstanding shares for Microbot Medical Inc?
Microbot Medical Inc has a total outstanding shares of 67.15